Browsing by Author "Bilici, A."

Now showing 1 - 3 of 3

Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?
(2019-01-01) Olmez, O. F.; Bilici, A.; Gursoy, P.; Cubukcu, E.; Yildiz, O.; Sakin, A.; Korkmaz, T.; Cil, I.; Cakar, B.; Menekse, S.; Demir, T.; Acikgoz, O.; Hamdard, J.
Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer
(2019-01-01) Bilici, A.; Olmez, O. F.; Gursoy, P.; Cubukcu, E.; Yildiz, O.; Sakin, A.; Korkmaz, T.; Cil, I.; Cakar, B.; Menekse, S.; Demir, T.; Acikgoz, O.; Hamdard, J.
The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)
(ELSEVIER, 2020-01-01) Olmez, O. F.; Bilici, A.; Er, O.; Sevinc, A.; Akman, T.; Uslu, R.; Mandel, N. M.; Yalcin, S.; Teomete, M.; Gorumlu, G.; Demir, A.; Namal, E.; Alici, S.; Selcukbiricik, F.; Bavbek, S.; Paksoy, F.; Basaran, G.; Ozer, L.; Sener, N.; Harputluoglu, H.